These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3066172)

  • 61. Human apolipoprotein B: complete cDNA sequence and identification of structural domains of the protein.
    Scott J; Pease RJ; Powell LM; Wallis SC; McCarthy BJ; Mahley RW; Levy-Wilson B; Knott TJ
    Biochem Soc Trans; 1987 Apr; 15(2):195-9. PubMed ID: 3556259
    [No Abstract]   [Full Text] [Related]  

  • 62. RNA editing: a novel mechanism for the regulation of dietary cholesterol absorption.
    Scott J
    Trans Med Soc Lond; 1989-1990; 106():51-9. PubMed ID: 2562621
    [No Abstract]   [Full Text] [Related]  

  • 63. [Familial defective apolipoprotein B-100].
    Nohara A; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):41-5. PubMed ID: 9645004
    [No Abstract]   [Full Text] [Related]  

  • 64. [Familial defective apolipoprotein B100: FDB].
    Nohara A; Mabuchi H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():47-54. PubMed ID: 11347116
    [No Abstract]   [Full Text] [Related]  

  • 65. [Apolipoprotein B-100 variants].
    Nohara A; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):33-6. PubMed ID: 9645001
    [No Abstract]   [Full Text] [Related]  

  • 66. The molecular and cell biology of apolipoprotein-B.
    Scott J
    Mol Biol Med; 1989 Feb; 6(1):65-80. PubMed ID: 2666820
    [No Abstract]   [Full Text] [Related]  

  • 67. [Familial combined hyperlipidemia].
    Takagi A; Ikeda Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):76-9. PubMed ID: 9645012
    [No Abstract]   [Full Text] [Related]  

  • 68. Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans.
    Raabe M; Kim E; Véniant M; Nielsen LB; Young SG
    Proc Assoc Am Physicians; 1998; 110(6):521-30. PubMed ID: 9824535
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Apolipoprotein B100 and LDL receptors: genetic and metabolic aspects].
    Chapman MJ
    Journ Annu Diabetol Hotel Dieu; 1991; ():35-7. PubMed ID: 1653378
    [No Abstract]   [Full Text] [Related]  

  • 70. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein clearance and atherogenesis.
    Bucala R
    Nephrol Dial Transplant; 1996; 11 Suppl 5():17-9. PubMed ID: 9044301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apolipoprotein B gene: plasma cholesterol and atherosclerosis.
    Scott J; Pease RJ; Powell LM; Wallis SC; McCarthy BJ; Mahley RW; Levy-Wilson B; Knott TJ
    Biochem Soc Symp; 1987; 53():155-63. PubMed ID: 3332766
    [No Abstract]   [Full Text] [Related]  

  • 72. [Apolipoprotein B].
    Yamamura T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():105-9. PubMed ID: 15658275
    [No Abstract]   [Full Text] [Related]  

  • 73. Molecular biology of human apolipoprotein B and related diseases.
    Zannis VI; Hussain MM; Hadzopoulou-Cladaras M; Kouvatsi A; Kardassis D; Cladaras C
    Adv Exp Med Biol; 1988; 243():107-21. PubMed ID: 3066172
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.